AS Latvijas Juras medicinas centrs (UOM.MU)
EUR 6.0
(0.0%)
EUR 6.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -14.16 Thousand EUR | -102.26% |
| 2022 | 625.72 Thousand EUR | -28.92% |
| 2021 | 880.25 Thousand EUR | 221.79% |
| 2020 | 273.55 Thousand EUR | 66.64% |
| 2019 | 164.16 Thousand EUR | 374.15% |
| 2018 | 34.62 Thousand EUR | -84.54% |
| 2017 | 223.95 Thousand EUR | 328.0% |
| 2016 | -98.22 Thousand EUR | 73.83% |
| 2015 | -375.31 Thousand EUR | -134.31% |
| 2014 | 1.09 Million EUR | 446.89% |
| 2013 | -315.37 Thousand EUR | -224.63% |
| 2012 | -97.14 Thousand EUR | 16.83% |
| 2011 | -116.81 Thousand EUR | 21.46% |
| 2010 | -148.73 Thousand EUR | -78.38% |
| 2009 | -83.38 Thousand EUR | -11860.51% |
| 2008 | 709.00 EUR | -99.78% |
| 2007 | 322.77 Thousand EUR | 1.96% |
| 2006 | 316.58 Thousand EUR | 25.29% |
| 2005 | 252.67 Thousand EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 91.32 Thousand EUR | 192.58% |
| 2024 Q2 | -119.75 Thousand EUR | -231.13% |
| 2023 Q4 | -98.64 Thousand EUR | -134.69% |
| 2023 Q1 | -108.33 Thousand EUR | -138.8% |
| 2023 FY | -14.16 Thousand EUR | -102.26% |
| 2023 Q3 | 284.38 Thousand EUR | 535.95% |
| 2023 Q2 | -65.23 Thousand EUR | 39.79% |
| 2022 Q1 | 377.87 Thousand EUR | 42.34% |
| 2022 Q3 | 83.18 Thousand EUR | 237.43% |
| 2022 Q2 | -60.52 Thousand EUR | -116.02% |
| 2022 Q4 | 279.22 Thousand EUR | 235.68% |
| 2022 FY | 625.72 Thousand EUR | -28.92% |
| 2021 Q3 | 285.67 Thousand EUR | 125.21% |
| 2021 Q2 | 126.84 Thousand EUR | -37.28% |
| 2021 Q4 | 265.47 Thousand EUR | -7.07% |
| 2021 FY | 880.25 Thousand EUR | 221.79% |
| 2021 Q1 | 202.26 Thousand EUR | 326.87% |
| 2020 FY | 273.55 Thousand EUR | 66.64% |
| 2020 Q1 | 79.42 Thousand EUR | -0.5% |
| 2020 Q2 | 78.51 Thousand EUR | -1.15% |
| 2020 Q3 | 204.76 Thousand EUR | 160.79% |
| 2020 Q4 | -89.15 Thousand EUR | -143.54% |
| 2019 Q4 | 79.82 Thousand EUR | -60.4% |
| 2019 Q1 | 14.45 Thousand EUR | -80.08% |
| 2019 Q3 | 201.59 Thousand EUR | 253.05% |
| 2019 FY | 164.16 Thousand EUR | 374.15% |
| 2019 Q2 | -131.72 Thousand EUR | -1011.08% |
| 2018 Q1 | 112.66 Thousand EUR | -10.02% |
| 2018 FY | 34.62 Thousand EUR | -84.54% |
| 2018 Q4 | 72.57 Thousand EUR | 19.58% |
| 2018 Q3 | 60.69 Thousand EUR | 128.72% |
| 2018 Q2 | -211.31 Thousand EUR | -287.57% |
| 2017 Q2 | -218.64 Thousand EUR | -250.78% |
| 2017 Q1 | 145 Thousand EUR | 206.92% |
| 2017 FY | 223.95 Thousand EUR | 328.0% |
| 2017 Q3 | 172.39 Thousand EUR | 178.84% |
| 2017 Q4 | 125.2 Thousand EUR | -27.37% |
| 2016 Q1 | 45.16 Thousand EUR | 133.28% |
| 2016 Q4 | -135.62 Thousand EUR | -353.73% |
| 2016 FY | -98.22 Thousand EUR | 73.83% |
| 2016 Q3 | 53.45 Thousand EUR | 187.31% |
| 2016 Q2 | -61.22 Thousand EUR | -235.55% |
| 2015 Q4 | -135.72 Thousand EUR | -18.05% |
| 2015 Q3 | -114.97 Thousand EUR | -223.63% |
| 2015 Q1 | -89.08 Thousand EUR | -109.83% |
| 2015 Q2 | -35.52 Thousand EUR | 60.12% |
| 2015 FY | -375.31 Thousand EUR | -134.31% |
| 2014 Q4 | 905.87 Thousand EUR | 477.48% |
| 2014 Q1 | 74.42 Thousand EUR | -34.3% |
| 2014 Q3 | 156.86 Thousand EUR | 463.35% |
| 2014 FY | 1.09 Million EUR | 446.89% |
| 2014 Q2 | -43.17 Thousand EUR | -158.01% |
| 2013 Q4 | 113.28 Thousand EUR | 356.77% |
| 2013 FY | -315.37 Thousand EUR | -224.63% |
| 2013 Q3 | 24.8 Thousand EUR | 110.25% |
| 2013 Q1 | -211.38 Thousand EUR | -189.19% |
| 2013 Q2 | -242.08 Thousand EUR | -14.52% |
| 2012 Q4 | 237 Thousand EUR | 272.32% |
| 2012 FY | -97.14 Thousand EUR | 16.83% |
| 2012 Q1 | -28.63 Thousand EUR | -136.55% |
| 2012 Q2 | -167.97 Thousand EUR | -486.55% |
| 2012 Q3 | -137.53 Thousand EUR | 18.12% |
| 2011 Q2 | -168.31 Thousand EUR | -1272.98% |
| 2011 FY | -116.81 Thousand EUR | 21.46% |
| 2011 Q1 | 14.34 Thousand EUR | 138.75% |
| 2011 Q4 | 78.34 Thousand EUR | 290.19% |
| 2011 Q3 | -41.19 Thousand EUR | 75.53% |
| 2010 Q4 | -37.02 Thousand EUR | -112.38% |
| 2010 Q1 | -129.02 Thousand EUR | -51.89% |
| 2010 FY | -148.73 Thousand EUR | -78.38% |
| 2010 Q2 | -281.76 Thousand EUR | -118.38% |
| 2010 Q3 | 299.08 Thousand EUR | 206.15% |
| 2009 Q2 | 33.88 Thousand EUR | -49.13% |
| 2009 Q3 | -98.92 Thousand EUR | -391.95% |
| 2009 FY | -83.38 Thousand EUR | -11860.51% |
| 2009 Q4 | -84.94 Thousand EUR | 14.13% |
| 2009 Q1 | 66.6 Thousand EUR | 0.0% |
| 2008 FY | 709.00 EUR | -99.78% |
| 2007 FY | 322.77 Thousand EUR | 1.96% |
| 2006 FY | 316.58 Thousand EUR | 25.29% |
| 2005 FY | 252.67 Thousand EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|